Abstract
Background: Bright light treatment is a therapeutic intervention mainly used to treat sleep and circadian disturbances in Alzheimer’s disease (AD) patients. Recently, a handful of studies also focused on the effect on cognition and behavior. Conflicting findings are reported in the literature, and no definite conclusions have been drawn about its specific therapeutic effect. Summary: The aim of this review is to provide a critical evaluation of available evidence in this field, highlighting the specific characteristics of effective bright light treatment. Eligible studies were required to assess at least one of the following outcome measures: sleep, cognition, mood, and/or behavior (e.g., depression, agitation). A total of 32 articles were included in this systematic review and identified as research intervention studies about light treatment in AD. The quality of the papers was evaluated based on the US Preventive Service Task Force guidelines. Key Messages: Overall, the current literature suggests that the effects of light treatment in AD patients are mixed and may be influenced by several factors, but with a general trend toward a positive effect. Bright light seems to be a promising intervention treatment without significant adverse effects; therefore, further well-designed randomized controlled trials are needed taking into account the highlighted recommendations.
References
1.
Hickman
RA
, Faustin
A
, Wisniewski
T
. Alzheimer disease and its growing epidemic: risk factors, biomarkers, and the urgent need for therapeutics
. Neurol Clin
. 2016
Nov
;34
(4
):941
–53
.
[PubMed]
0733-86192.
Peter-Derex
L
, Yammine
P
, Bastuji
H
, Croisile
B
. Sleep and Alzheimer’s disease
. Sleep Med Rev
. 2015
Feb
;19
:29
–38
.
[PubMed]
1087-07923.
McCurry
SM
, Reynolds
CF
3rd, Ancoli-Israel
S
, Teri
L
, Vitiello
MV
. Treatment of sleep disturbance in Alzheimer’s disease
. Sleep Med Rev
. 2000
Dec
;4
(6
):603
–28
.
[PubMed]
1087-07924.
Ju
YE
, Lucey
BP
, Holtzman
DM
. Sleep and Alzheimer disease pathology—a bidirectional relationship
. Nat Rev Neurol
. 2014
Feb
;10
(2
):115
–9
.
[PubMed]
1759-47585.
Liu
RY
, Zhou
JN
, Hoogendijk
WJ
, van Heerikhuize
J
, Kamphorst
W
, Unmehopa
UA
, et al. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression
. J Neuropathol Exp Neurol
. 2000
Apr
;59
(4
):314
–22
.
[PubMed]
0022-30696.
Stopa
EG
, Volicer
L
, Kuo-Leblanc
V
, Harper
D
, Lathi
D
, Tate
B
, et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia
. J Neuropathol Exp Neurol
. 1999
Jan
;58
(1
):29
–39
.
[PubMed]
0022-30697.
Blanks
JC
, Hinton
DR
, Sadun
AA
, Miller
CA
. Retinal ganglion cell degeneration in Alzheimer’s disease
. Brain Res
. 1989
Nov
;501
(2
):364
–72
.
[PubMed]
0006-89938.
Sadun
AA
, Bassi
CJ
. Optic nerve damage in Alzheimer’s disease
. Ophthalmology
. 1990
Jan
;97
(1
):9
–17
.
[PubMed]
0161-64209.
Hinton
DR
, Sadun
AA
, Blanks
JC
, Miller
CA
. Optic-nerve degeneration in Alzheimer’s disease
. N Engl J Med
. 1986
Aug
;315
(8
):485
–7
.
[PubMed]
0028-479310.
Coppola
G
, Di Renzo
A
, Ziccardi
L
, Martelli
F
, Fadda
A
, Manni
G
, et al.: Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis. PLoS One 2015
; 7:10(8).11.
den Haan
J
, Verbraak
FD
, Visser
PJ
, Bouwman
FH
. Retinal thickness in Alzheimer’s disease: A systematic review and meta-analysis
. Alzheimers Dement (Amst)
. 2017
Jan
;6
:162
–70
.
[PubMed]
2352-872912.
Kirbas
S
, Turkyilmaz
K
, Anlar
O
, Tufekci
A
, Durmus
M
. Retinal nerve fiber layer thickness in patients with Alzheimer disease
. J Neuroophthalmol
. 2013
Mar
;33
(1
):58
–61
.
[PubMed]
1070-802213.
Paquet
C
, Boissonnot
M
, Roger
F
, Dighiero
P
, Gil
R
, Hugon
J
. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease
. Neurosci Lett
. 2007
Jun
;420
(2
):97
–9
.
[PubMed]
0304-394014.
Cotman
SL
, Halfter
W
, Cole
GJ
. Agrin binds to β-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer’s disease brain
. Mol Cell Neurosci
. 2000
Feb
;15
(2
):183
–98
.
[PubMed]
1044-743115.
Koronyo-Hamaoui
M
, Koronyo
Y
, Ljubimov
AV
, Miller
CA
, Ko
MK
, Black
KL
, et al. Identification of amyloid plaques in retinas from Alzheimer’s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model
. Neuroimage
. 2011
Jan
;54
Suppl 1
:S204
–17
.
[PubMed]
1053-811916.
Ning
A
, Cui
J
, To
E
, Ashe
KH
, Matsubara
J
. Amyloid-β deposits lead to retinal degeneration in a mouse model of Alzheimer disease
. Invest Ophthalmol Vis Sci
. 2008
Nov
;49
(11
):5136
–43
.
[PubMed]
0146-040417.
Koronyo
Y
, Biggs
D
, Barron
E
, Boyer
DS
, Pearlman
JA
, Au
WJ
, et al.: Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.
JCI Insight 2017
; 17:2(16).18.
La Morgia
C
, Ross-Cisneros
FN
, Koronyo
Y
, Hannibal
J
, Gallassi
R
, Cantalupo
G
, et al. Melanopsin retinal ganglion cell loss in Alzheimer disease
. Ann Neurol
. 2016
Jan
;79
(1
):90
–109
.
[PubMed]
0364-513419.
Berson
DM
, Dunn
FA
, Takao
M
. Phototransduction by retinal ganglion cells that set the circadian clock
. Science
. 2002
Feb
;295
(5557
):1070
–3
.
[PubMed]
0036-807520.
Hattar
S
, Liao
HW
, Takao
M
, Berson
DM
, Yau
KW
. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity
. Science
. 2002
Feb
;295
(5557
):1065
–70
.
[PubMed]
0036-807521.
Hannibal
J
, Fahrenkrug
J
. Neuronal input pathways to the brain’s biological clock and their functional significance
. Adv Anat Embryol Cell Biol
. 2006
;182
:1
–71
.
[PubMed]
0301-555622.
Sadun
AA
, Schaechter
JD
, Smith
LE
. A retinohypothalamic pathway in man: light mediation of circadian rhythms
. Brain Res
. 1984
Jun
;302
(2
):371
–7
.
[PubMed]
0006-899323.
Feng
R
, Li
L
, Yu
H
, Liu
M
, Zhao
W
. Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer’s disease (Review)
. Mol Med Rep
. 2016
Apr
;13
(4
):3397
–400
.
[PubMed]
1791-299724.
Saeed
Y
, Abbott
SM
. Circadian Disruption Associated with Alzheimer’s Disease
. Curr Neurol Neurosci Rep
. 2017
Apr
;17
(4
):29
.
[PubMed]
1528-404225.
Haffmans
PM
, Sival
RC
, Lucius
SA
, Cats
Q
, van Gelder
L
. Bright light therapy and melatonin in motor restless behaviour in dementia: a placebo-controlled study
. Int J Geriatr Psychiatry
. 2001
Jan
;16
(1
):106
–10
.
[PubMed]
0885-623026.
Mishima
K
, Tozawa
T
, Satoh
K
, Matsumoto
Y
, Hishikawa
Y
, Okawa
M
. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-waking
. Biol Psychiatry
. 1999
Feb
;45
(4
):417
–21
.
[PubMed]
0006-322327.
Satlin
A
, Volicer
L
, Ross
V
, Herz
L
, Campbell
S
. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer’s disease
. Am J Psychiatry
. 1992
Aug
;149
(8
):1028
–32
.
[PubMed]
0002-953X28.
Forbes
D
, Culum
I
, Lischka
AR
, Morgan
DG
, Peacock
S
, Forbes
J
, et al. Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia
. Cochrane Database Syst Rev
. 2009
Oct
;(4
):CD003946
.
[PubMed]
1469-493X29.
Forbes
D
, Blake
CM
, Thiessen
EJ
, Peacock
S
, Hawranik
P
. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia
. Cochrane Database Syst Rev
. 2014
Feb
;(2
):CD003946
.
[PubMed]
1469-493X30.
Millán-Calenti
JC
, Lorenzo-López
L
, Alonso-Búa
B
, de Labra
C
, González-Abraldes
I
, Maseda
A
. Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
. Clin Interv Aging
. 2016
Feb
;11
:175
–84
.
[PubMed]
1176-909231.
Salami
O
, Lyketsos
C
, Rao
V
. Treatment of sleep disturbance in Alzheimer’s dementia
. Int J Geriatr Psychiatry
. 2011
Aug
;26
(8
):771
–82
.
[PubMed]
0885-623032.
Richardson
WS
, Wilson
MC
, Nishikawa
J
, Hayward
RS
. The well-built clinical question: a key to evidence-based decisions
. ACP J Club
. 1995
Nov-Dec
;123
(3
):A12
–3
.
[PubMed]
1056-875133.
U.S. Preventive Services Task Force
. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force
. DIANE Publishing
; 1989
. p. 24
.34.
Ancoli-Israel
S
, Gehrman
P
, Martin
JL
, Shochat
T
, Marler
M
, Corey-Bloom
J
, et al. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patients
. Behav Sleep Med
. 2003
a;1
(1
):22
–36
.
[PubMed]
1540-200235.
Ancoli-Israel
S
, Martin
JL
, Kripke
DF
, Marler
M
, Klauber
MR
. Effect of light treatment on sleep and circadian rhythms in demented nursing home patients
. J Am Geriatr Soc
. 2002
Feb
;50
(2
):282
–9
.
[PubMed]
0002-861436.
Figueiro
MG
, Plitnick
BA
, Lok
A
, Jones
GE
, Higgins
P
, Hornick
TR
, et al. Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer’s disease and related dementia living in long-term care facilities
. Clin Interv Aging
. 2014
Sep
;9
(9
):1527
–37
.
[PubMed]
1176-909237.
Figueiro
MG
, Hunter
CM
, Higgins
P
, Hornick
T
, Jones
GE
, Plitnick
B
, et al. Tailored Lighting Intervention for Persons with Dementia and Caregivers Living at Home
. Sleep Health
. 2015
Dec
;1
(4
):322
–30
.
[PubMed]
2352-721838.
Sloane
PD
, Figueiro
M
, Garg
S
, Cohen
LW
, Reed
D
, Williams
CS
, et al. Effect of home-based light treatment on persons with dementia and their caregivers
. Light Res Technol
. 2015
Apr
;47
(2
):161
–76
.
[PubMed]
1477-153539.
Van Someren
EJ
, Kessler
A
, Mirmiran
M
, Swaab
DF
. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients
. Biol Psychiatry
. 1997
May
;41
(9
):955
–63
.
[PubMed]
0006-322340.
Fontana Gasio
P
, Kräuchi
K
, Cajochen
C
, Someren
E
, Amrhein
I
, Pache
M
, et al. Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly
. Exp Gerontol
. 2003
Jan-Feb
;38
(1-2
):207
–16
.
[PubMed]
0531-556541.
Fetveit
A
, Skjerve
A
, Bjorvatn
B
. Bright light treatment improves sleep in institutionalised elderly—an open trial
. Int J Geriatr Psychiatry
. 2003
Jun
;18
(6
):520
–6
.
[PubMed]
0885-623042.
Fetveit
A
, Bjorvatn
B
. Bright-light treatment reduces actigraphic-measured daytime sleep in nursing home patients with dementia: a pilot study
. Am J Geriatr Psychiatry
. 2005
May
;13
(5
):420
–3
.
[PubMed]
1064-748143.
Fetveit
A
, Bjorvatn
B
. The effects of bright-light therapy on actigraphical measured sleep last for several weeks post-treatment. A study in a nursing home population
. J Sleep Res
. 2004
Jun
;13
(2
):153
–8
.
[PubMed]
0962-110544.
Dowling
GA
, Hubbard
EM
, Mastick
J
, Luxenberg
JS
, Burr
RL
, Van Someren
EJ
. Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer’s disease
. Int Psychogeriatr
. 2005
a Jun
;17
(2
):221
–36
.
[PubMed]
1041-610245.
Dowling
GA
, Mastick
J
, Hubbard
EM
, Luxenberg
JS
, Burr
RL
. Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer’s disease
. Int J Geriatr Psychiatry
. 2005
b Aug
;20
(8
):738
–43
.
[PubMed]
0885-623046.
Yamadera
H
, Ito
T
, Suzuki
H
, Asayama
K
, Ito
R
, Endo
S
. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia
. Psychiatry Clin Neurosci
. 2000
Jun
;54
(3
):352
–3
.
[PubMed]
1323-131647.
Skjerve
A
, Holsten
F
, Aarsland
D
, Bjorvatn
B
, Nygaard
HA
, Johansen
IM
. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia
. Psychiatry Clin Neurosci
. 2004
Aug
;58
(4
):343
–7
.
[PubMed]
1323-131648.
Burns
A
, Allen
H
, Tomenson
B
, Duignan
D
, Byrne
J
. Bright light therapy for agitation in dementia: a randomized controlled trial
. Int Psychogeriatr
. 2009
Aug
;21
(4
):711
–21
.
[PubMed]
1041-610249.
Koyama
E
, Matsubara
H
, Nakano
T
. Bright light treatment for sleep-wake disturbances in aged individuals with dementia
. Psychiatry Clin Neurosci
. 1999
Apr
;53
(2
):227
–9
.
[PubMed]
1323-131650.
Lyketsos
CG
, Lindell Veiel
L
, Baker
A
, Steele
C
. A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care
. Int J Geriatr Psychiatry
. 1999
Jul
;14
(7
):520
–5
.
[PubMed]
0885-623051.
Graf
A
, Wallner
C
, Schubert
V
, Willeit
M
, Wlk
W
, Fischer
P
, et al.: The effects of light therapy on mini-mental state examination scores in demented patients.
Biol Psychiatry 2001
; 1; 50(9):725-7.52.
Riemersma-van der Lek
RF
, Swaab
DF
, Twisk
J
, Hol
EM
, Hoogendijk
WJ
, Van Someren
EJ
. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial
. JAMA
. 2008
Jun
;299
(22
):2642
–55
.
[PubMed]
0098-748453.
Lovell
BB
, Ancoli-Israel
S
, Gevirtz
R
. Effect of bright light treatment on agitated behavior in institutionalized elderly subjects
. Psychiatry Res
. 1995
Jun
;57
(1
):7
–12
.
[PubMed]
0165-178154.
Mishima
K
, Okawa
M
, Hishikawa
Y
, Hozumi
S
, Hori
H
, Takahashi
K
. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia
. Acta Psychiatr Scand
. 1994
Jan
;89
(1
):1
–7
.
[PubMed]
0001-690X55.
Ancoli-Israel
S
, Martin
JL
, Gehrman
P
, Shochat
T
, Corey-Bloom
J
, Marler
M
, et al. Effect of light on agitation in institutionalized patients with severe Alzheimer disease
. Am J Geriatr Psychiatry
. 2003
b Mar-Apr
;11
(2
):194
–203
.
[PubMed]
1064-748156.
Barrick
AL
, Sloane
PD
, Williams
CS
, Mitchell
CM
, Connell
BR
, Wood
W
, et al. Impact of ambient bright light on agitation in dementia
. Int J Geriatr Psychiatry
. 2010
Oct
;25
(10
):1013
–21
.
[PubMed]
0885-623057.
Dowling
GA
, Graf
CL
, Hubbard
EM
, Luxenberg
JS
. Light treatment for neuropsychiatric behaviors in Alzheimer’s disease
. West J Nurs Res
. 2007
Dec
;29
(8
):961
–75
.
[PubMed]
0193-945958.
Onega
LL
, Pierce
TW
, Epperly
L
. Effect of Bright Light Exposure on Depression and Agitation in Older Adults with Dementia
. Issues Ment Health Nurs
. 2016
Sep
;37
(9
):660
–7
.
[PubMed]
0161-284059.
Hickman
SE
, Barrick
AL
, Williams
CS
, Zimmerman
S
, Connell
BR
, Preisser
JS
, et al. The effect of ambient bright light therapy on depressive symptoms in persons with dementia
. J Am Geriatr Soc
. 2007
Nov
;55
(11
):1817
–24
.
[PubMed]
0002-861460.
Schindler
SD
, Graf
A
, Fischer
P
, Tölk
A
, Kasper
S
. Paranoid delusions and hallucinations and bright light therapy in Alzheimer’s disease
. Int J Geriatr Psychiatry
. 2002
Nov
;17
(11
):1071
–2
.
[PubMed]
0885-623061.
Mishima
K
, Hishikawa
Y
, Okawa
M
. Randomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer’s type
. Chronobiol Int
. 1998
Nov
;15
(6
):647
–54
.
[PubMed]
0742-052862.
Sekiguchi
H
, Iritani
S
, Fujita
K
. Bright light therapy for sleep disturbance in dementia is most effective for mild to moderate Alzheimer’s type dementia: a case series
. Psychogeriatrics
. 2017
Sep
;17
(5
):275
–81
.
[PubMed]
1346-350063.
Dubois
B
, Hampel
H
, Feldman
HH
, Scheltens
P
, Aisen
P
, Andrieu
S
, et al.; Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer’s Association on “The Preclinical State of AD”; July 23, 2015; Washington DC, USA
. Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria
. Alzheimers Dement
. 2016
Mar
;12
(3
):292
–323
.
[PubMed]
1552-526064.
Sloane
PD
, Williams
CS
, Mitchell
CM
, Preisser
JS
, Wood
W
, Barrick
AL
, et al. High-intensity environmental light in dementia: effect on sleep and activity
. J Am Geriatr Soc
. 2007
Oct
;55
(10
):1524
–33
.
[PubMed]
0002-861465.
Most
EI
, Scheltens
P
, Van Someren
EJ
. Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light—a randomized clinical trial
. Trials
. 2010
Feb
;11
(1
):19
.
[PubMed]
1745-621566.
Vandewalle
G
, Schmidt
C
, Albouy
G
, Sterpenich
V
, Darsaud
A
, Rauchs
G
, et al. Brain responses to violet, blue, and green monochromatic light exposures in humans: prominent role of blue light and the brainstem
. PLoS One
. 2007
Nov
;2
(11
):e1247
.
[PubMed]
1932-620367.
Oldham
MA
, Ciraulo
DA
. Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system
. Chronobiol Int
. 2014
Apr
;31
(3
):305
–19
.
[PubMed]
0742-052868.
Al-Karawi
D
, Jubair
L
. Bright light therapy for nonseasonal depression: meta-analysis of clinical trials
. J Affect Disord
. 2016
Jul
;198
(198
):64
–71
.
[PubMed]
0165-032769.
Beauchamp
MT
, Lundgren
JD
. A Systematic Review of Bright Light Therapy for Eating Disorders
. Prim Care Companion CNS Disord
. 2016
Oct
;18
(5
).
[PubMed]
2155-7772© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
